S&P Futures
4,011.50 +4.25 (+0.11%) Dow Futures
32,656.00 +25.00 (+0.08%) Nasdaq Futures
12,812.75 +24.25 (+0.19%) Russell 2000 Futures
1,769.80 +2.50 (+0.14%) Crude Oil
72.88 +0.07 (+0.10%) Gold
1,959.40 +5.60 (+0.29%)
Longboard Pharmaceuticals, Inc. (LBPH)
Chart Events
Performance Outlook
| Previous Close | 4.1500 |
| Open | 4.1500 |
| Bid | 4.0000 x 800 |
| Ask | 6.6400 x 800 |
| Day's Range | 4.0189 - 4.3500 |
| 52 Week Range | 2.7000 - 6.2300 |
| Volume | |
| Avg. Volume | 28,651 |
| Market Cap | 72.993M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.6210 |
| Earnings Date | May 03, 2023 - May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.00 |
- Zacks
Wall Street Analysts Predict an 184.81% Upside in Longboard Pharmaceuticals, Inc. (LBPH): Here's What You Should Know
The mean of analysts' price targets for Longboard Pharmaceuticals, Inc. (LBPH) points to an 184.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- Insider Monkey
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Q4 2022 Earnings Call Transcript
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Q4 2022 Earnings Call Transcript March 2, 2023 Operator: Good day and thank you for standing by. Welcome to the Longboard Pharmaceuticals Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. . Please be advised that today’s conference […]
- Business Wire
Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives
SAN DIEGO, March 02, 2023--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported financial results for the full year 2022.
